XTL Biopharmaceuticals Ltd
- Stock Issuer and Owners
| Due Diligence for Asset Managers |
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
|
| XTL Biopharmaceuticals Ltd |
| Ticker | XTLB |
| CIK # | 0001023549 |
| CUSIP | 98386D208 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | Xtl Biopharmaceuticals Ltd c/o Alston & Bird Llp, 90 Park Avenue, New York, NY 10016 |
| Source |
[EDGAR]
|
| Reg D Offering (Form D) |
Filed |
Raised |
Terms |
| XTL Biopharmaceuticals Ltd |
2017-03-29 |
2.8 M |
Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
|
| 13F Ownership Over Time | Holders | Shares Held |
| 2026-03-31 |
6 |
72,702 |
| 2025-12-31 |
6 |
329,727 |
| 2025-09-30 |
4 |
226,923 |
| 2025-06-30 |
5 |
228,496 |
| 2025-03-31 |
5 |
248,304 |
| 2024-12-31 |
4 |
228,193 |
| 2024-09-30 |
4 |
231,858 |
| 2024-06-30 |
5 |
253,058 |
| 2024-03-31 |
6 |
337,286 |
| 2023-12-31 |
6 |
278,984 |
| 2023-09-30 |
5 |
239,879 |
| 2023-06-30 |
4 |
240,259 |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 223755666, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 2, "random_n": 0.41432609944786947}
False
335064334